AKT1 and gastric cancer: Emerging evidence demonstrates that PI3K/AKT/mTOR signaling pathway is significantly correlated with the occurrence, prognosis, and metastasis of gastric cancer, and the PI3K/AKT/mTOR signaling pathway may be a molecular target and potential therapeutic strategy for the clinical diagnosis of gastric cancer46.